drugset / Trial / NCT00120718

The Effect of Fasudil on Vascular Function in Humans

NCT00120718

Phase 2 Completed 60 enrolled Brigham and Women's Hospital
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of the study is to evaluate how the rho kinase inhibitor, fasudil, affects vascular function in patients with atherosclerosis and hyperlipidemia.

Timeline

Start
2002-06
Primary completion
2007-01
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Fasudil Small molecule